Kala Pharmaceuticals' Series C Round

Kala Pharmaceuticals raised a round of funding on April 13, 2016.

Kala Pharmaceuticals (NASDAQ: KALA) is developing medicines that have the ability to rapidly and effectively penetrate mucosal barriers resulting in therapeutic efficacy and transformative treatment o…

Articles about Kala Pharmaceuticals' Series C Round: